REMONDIS Yun Tai CO., LTD.
Update：2025/12/03
Industries
Main Industry
Sustainability
Founded Year
2013
Unified Business No.
54643120
Status
Active
Number of Employees
0
Total Paid-in
Capital
300,000,000 (NT$)
Location of Company
Taiwan
, Changhua County
Website
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Taiwan Exosome Co., Ltd. was established in 2021, dedicated to the horizontal and vertical development of novel drugs using human, animal, and plant exosomes. The company conducts in-depth scientific research and development in exosome industry technology, utilizing the most professional knowledge, equipment, and advanced technology as the foundation. It focuses on developing treatments for difficult-to-treat diseases, including autoimmune diseases and sarcopenia. Taiwan Exosome also aims to establish a "Pharmaceutical-Grade Exosome Industry Technology Platform," which includes modules for exosome separation, purification, identification, and mass production technology, making it a leader across the upstream, midstream, and downstream regenerative medical industry chain.
